Ma C, Panaccione R, Xiao Y, Khandelwal Y, et al. REMIT-UC: Real World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis. Am J Gastroenterol 2022 Dec 8. doi: 10.14309/ajg.0000000000002129.
PMID: 36580497